Bradanicline
Daten werden ergänzt – meist innerhalb einer Minute fertig
Grundinformationen
- CAS
639489-84-2- Standard-SMILES
O=C(N[C@@H]1C2CCN(CC2)[C@H]1Cc1cccnc1)c1cc2ccccc2o1- InChIKey
OXKRFEWMSWPKKV-GHTZIAJQSA-N- Summenformel
- C22H23N3O2
- Durchschnittliche Molmasse
- 361,4 g/mol
- Monoisotopische Masse
- 361,17902698
Überblick
Bradanicline, a novel small molecule that modulates the activity of the neuronal nicotinic receptor (NNR) subtype known as alpha7(α7). Bradanicline belongs to a new class of drugs for the treatment of central nervous system diseases and disorders.
Namen und Bezeichner
- Bevorzugter Name
- Bradanicline
- IUPAC
- N-[(2S,3R)-2-(pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]octan-3-yl]-1-benzofuran-2-carboxamide
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
639489-84-2- PubChem CID
- 25147644
- DTXSID
DTXSID40213778- ChEMBL
CHEMBL1258006- UNII
- UM3821998K
- Nikkaji
- J3.283.372A
Eigenschaften
Berechnete StruktureigenschaftenWird ergänzt
- XLogP
- 3,5
- Polarare Oberfläche (TPSA)
- 58,4 Ų
- H-Brücken-Donoren
- 1
- H-Brücken-Akzeptoren
- 4
- Frei drehbare Bindungen
- 4
- Schwere Atome
- 27
- Formalladung
- 0
- Komplexität
- 534
Experimentelle und physikochemische Eigenschaften
Chemie und Industrie
Pharmakologische Informationen
Mechanism of Action
Bradanicline, a novel small molecule that modulates the activity of the neuronal nicotinic receptor (NNR) subtype known as alpha7(α7). The α7 NNR is associated with a variety of biological functions. In particular, the α7 NNR has been shown in animal studies to be an essential regulator of both inflammation arising from injury or infection and cognitive functions. α7 NNR plays a role in protecting neuronal cells from deterioration and death, a process known as neuroprotection.
Anbieter8 Anbieter
Zugehörige Reaktionen
Notizen zur Verbindung
Wird geladen…